Literature DB >> 15951099

Histories of depression, allopregnanolone responses to stress, and premenstrual symptoms in women.

Rebecca R Klatzkin1, A Leslie Morrow, Kathleen C Light, Cort A Pedersen, Susan S Girdler.   

Abstract

Twenty-six women meeting DSM criteria for premenstrual dysphoric disorder (PMDD) and 39 non-PMDD controls were tested for allopregnanolone (ALLO) responses to mental stress. Approximately half of each group had a history of depression (DEP) (14 PMDD, 17 non-PMDD), though all were free of current psychiatric illness. ALLO was sampled in response to venipuncture stress, after an extended baseline, and again 30 and 60 min following the onset of mental stressors. All women with prior DEP, regardless of PMDD status, showed a blunted ALLO stress response at 30 and 60 min (p < 0.05), and also failed to show the expected decrease from venipuncture to baseline rest (p = 0.08) compared to women with no prior DEP. Women with prior DEP did not show the expected correlation between progesterone and ALLO (r = 0.16) that was seen in those with no prior DEP (r = 0.37, p < 0.05). ALLO levels at extended baseline and blunted ALLO reactivity predicted more severe premenstrual symptoms, but only in PMDD women with prior DEP (p values <0.05). These results suggest that a history of DEP is associated with a failure of ALLO to be appropriately responsive to challenge, with alterations in the conversion of progesterone to ALLO, and confirm prior reports linking ALLO to symptoms in PMDD, but only in PMDD women with histories of DEP.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15951099     DOI: 10.1016/j.biopsycho.2005.02.007

Source DB:  PubMed          Journal:  Biol Psychol        ISSN: 0301-0511            Impact factor:   3.251


  24 in total

1.  5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.

Authors:  Pedro E Martinez; David R Rubinow; Lynnette K Nieman; Deloris E Koziol; A Leslie Morrow; Crystal E Schiller; Dahima Cintron; Karla D Thompson; Khursheed K Khine; Peter J Schmidt
Journal:  Neuropsychopharmacology       Date:  2013-08-14       Impact factor: 7.853

2.  Persistent alterations in biological profiles in women with abuse histories: influence of premenstrual dysphoric disorder.

Authors:  Susan S Girdler; Jane Leserman; Robertas Bunevicius; Rebecca Klatzkin; Cort A Pedersen; Kathleen C Light
Journal:  Health Psychol       Date:  2007-03       Impact factor: 4.267

3.  Antidepressant-like effects of Z-ligustilide on chronic unpredictable mild stress-induced depression in rats.

Authors:  Jian-Chun Ma; Hao-Liang Zhang; Hui-Ping Huang; Zao-Liang Ma; Su-Fang Chen; Zhi-Kun Qiu; Ji-Sheng Chen
Journal:  Exp Ther Med       Date:  2021-04-25       Impact factor: 2.447

4.  Allopregnanolone association with psychophysiological and cognitive functions during acute smoking abstinence in premenopausal women.

Authors:  Alicia M Allen; Mustafa al'Absi; Harry Lando; Sharon S Allen
Journal:  Exp Clin Psychopharmacol       Date:  2015-02       Impact factor: 3.157

Review 5.  Neurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: what is the current state of knowledge in humans?

Authors:  Shannon K Crowley; Susan S Girdler
Journal:  Psychopharmacology (Berl)       Date:  2014-04-23       Impact factor: 4.530

6.  Lower allopregnanolone during pregnancy predicts postpartum depression: An exploratory study.

Authors:  Lauren M Osborne; Fiona Gispen; Abanti Sanyal; Gayane Yenokyan; Samantha Meilman; Jennifer L Payne
Journal:  Psychoneuroendocrinology       Date:  2017-02-16       Impact factor: 4.905

7.  Menstrual phase, depressive symptoms, and allopregnanolone during short-term smoking cessation.

Authors:  Alicia M Allen; Mustafa al'Absi; Harry Lando; Dorothy Hatsukami; Sharon S Allen
Journal:  Exp Clin Psychopharmacol       Date:  2013-09-23       Impact factor: 3.157

Review 8.  Divergent neuroactive steroid responses to stress and ethanol in rat and mouse strains: relevance for human studies.

Authors:  Patrizia Porcu; A Leslie Morrow
Journal:  Psychopharmacology (Berl)       Date:  2014-04-26       Impact factor: 4.530

Review 9.  The role of sex steroids in catamenial epilepsy and premenstrual dysphoric disorder: implications for diagnosis and treatment.

Authors:  Constance Guille; Susan Spencer; Idil Cavus; C Neill Epperson
Journal:  Epilepsy Behav       Date:  2008-03-17       Impact factor: 2.937

10.  Depressive symptoms as predictors of discontinuation of treatment of menorrhagia by levonorgestrel-releasing intrauterine system.

Authors:  Marko Elovainio; Juha Teperi; Anna-Mari Aalto; Seija Grenman; Aarre Kivelä; Erkki Kujansuu; Sirkku Vuorma; Merja Yliskoski; Jorma Paavonen; Ritva Hurskainen
Journal:  Int J Behav Med       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.